Integral Diagnostics Limited (ASX:IDX)

Integral Diagnostics Cash Flow Statement

Financials in millions AUD. Fiscal year is July - June.

Operating Activities

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022
Net Income	21.93	2.69	-60.7	25.04	14.6
Depreciation & Amortization	67.22	53.27	41.53	43.49	36.7
Other Amortization	7.44	7.29	5.77	0.39	0.41
Loss (Gain) From Sale of Assets	-0.57	0.06	-0.02	0.02	-0.18
Asset Writedown & Restructuring Costs	-	0.54	74.64	-	-
Loss (Gain) on Equity Investments	-	-	0.06	0.33	0.16
Stock-Based Compensation	2.48	1.22	1.37	2.21	-0.64
Provision & Write-off of Bad Debts	0.3	1.17	0.64	0.36	-0.21
Other Operating Activities	5.17	-3.63	-1.11	-16.5	-1.59
Change in Accounts Receivable	-1.76	-0.03	-3.25	-0.35	-3.44
Change in Accounts Payable	1.41	3.77	1.69	3.16	0.43
Change in Unearned Revenue	-	-1.08	-0.04	-0.08	-
Change in Income Taxes	0.66	1.49	-0.25	5.36	-9.2
Change in Other Net Operating Assets	-4.76	6.86	0.54	5.63	0.7
Operating Cash Flow	95.24	73.77	66.16	67.28	37.1
Operating Cash Flow Growth	29.10%	11.51%	-1.66%	81.34%	-46.67%

Investing Activities

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022
Capital Expenditures	-49.64	-59.76	-23.88	-44	-27.77
Sale of Property, Plant & Equipment	0.32	0.31	-	-	-
Cash Acquisitions	-	14.93	-4.03	-84.96	-27.92
Other Investing Activities	-	-20.48	-	-	-
Investing Cash Flow	-49.32	-64.99	-27.9	-128.96	-55.69

Financing Activities

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022
Long-Term Debt Issued	10	343.38	-	43.05	114.15
Long-Term Debt Repaid	-30.73	-326.65	-17.35	-60.19	-101.11
Net Debt Issued (Repaid)	-20.73	16.73	-17.35	-17.14	13.04
Issuance of Common Stock	-	-	-	2.2	91.83
Common Dividends Paid	-25.93	-15.46	-12.1	-12.64	-20.86
Other Financing Activities	1.17	-0.56	-	-	-2.88
Financing Cash Flow	-45.48	0.71	-29.45	-27.58	81.13

Net Cash Flow

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022
Foreign Exchange Rate Adjustments	-1.25	0.18	-0.22	0.05	-1.55
Miscellaneous Cash Flow Adjustments	-	-	-	-0.13	-
Net Cash Flow	-0.82	9.67	8.58	-89.34	60.99

Free Cash Flow

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022
Free Cash Flow	45.6	14.01	42.28	23.28	9.33
Free Cash Flow Growth	225.41%	-66.86%	81.61%	149.53%	-81.08%
Free Cash Flow Margin	5.78%	2.23%	9.00%	5.28%	2.58%
Free Cash Flow Per Share	0.12	0.04	0.18	0.10	0.04
Levered Free Cash Flow	53.54	60.91	37.44	20.14	16.84
Unlevered Free Cash Flow	73.71	77.71	50.95	31.18	22.98

Additional Metrics

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022
Cash Interest Paid	28.77	30.73	22.12	17.81	10.33
Cash Income Tax Paid	13.69	4.01	-1.71	1.99	17.45
Change in Working Capital	-8.73	11.17	3.98	11.95	-12.15

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Aug 27, 2026

Data Sources Report a data error